Ethris
PrivateLast Round
Debt
Sep 10, 2026
Est. Valuation
$154.58M
Total Funding Raised
$96.64M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Ethris is a biotechnology company that develops messenger RNA (mRNA) based therapeutics and vaccines, with a focus on respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ethris Comparables
Compare Ethris with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| eTheRNA | 87% | |
| Pantherna Therapeutics | 86% | |
| Genevant Sciences | 85% | |
Ethris Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Sep 10, 2026 | ||||
| Grant | May 6, 2025 | ||||
| Grant | Feb 11, 2025 | ||||
| Convertible Debt | Jun 18, 2024 | ||||
| VC Round | Jun 18, 2024 | ||||
Grant | Feb 25, 2024 |
Key People
Founding team and executive leadership
Ethris Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CEPI | Grant |
| European Investment Bank Group | Debt |
| Bill & Melinda Gates Foundation | VC Round |
| European Health and Digital Executive Agency | Grant |
| Central Innovation Program for SMEs | Grant |
| Laureus Capital | Series B |
| EU4Health Programme | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 10, 2026
$35M round led by European Investment Bank Group
- Aug 20, 2026
Monthly visitors increased 129% MoM.
Ethris Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ethris's valuation, stock price, and market status.